Sarepta Therapeutics: A Strong Opportunity Amidst The Panic

Core Insights - Sarepta Therapeutics has stabilized after a tumultuous period and is now available at a historic discount, presenting a potential buying opportunity for investors [1] - The company has strong patient support and has reached a resolution, indicating positive developments in its operations [1] Investment Strategy - The focus is on a long/short equity strategy in small to mid-cap biotech, emphasizing thorough modeling for new drugs [1] - There is a search for de-risked but overlooked assets, suggesting a strategic approach to identifying investment opportunities [1]